STOCK TITAN
  1. Home
  2. BDMDW

Baird Medical Investment Holdings Warrant (BDMDW) Stock Price, News & Analysis

BDMDW NASDAQ
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
45 86 sessions, November 3, 2025 to November 5, 2026
Largest daily move
-59.6% close of November 2, 2026
1-year change
-62.1% closing prices, November 3, 2025 to November 5, 2026
1-month change
-37.1% closing prices, October 5, 2026 to November 5, 2026

Company Description

BDMDW has declined 62.1% over the past year. The last closing price was $0.0190.

For FY2025, Baird Medical Investment Holdings Warrant reported revenue of $22.5M with net income of -$27.3M and diluted earnings per share of -$0.98.

This page collects what Stock Titan holds for BDMDW, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

Chart
$0.0189
-0.53%
-0.0001
Last updated: November 6, 2026 at 10:06
-62.1%
Performance 1 year
-
Market Cap
-
Shares outstanding

Baird Medical Investment Holdings Warrant (BDMDW) closed at $0.0190 on November 5, 2026. Over the past 12 months, the price has lost 62.1%.

See what a $1,000 investment in BDMDW would be worth today

Average down calculator for BDMDW

BDMDW Metrics & Rankings

Revenue
$22.5M
#3,543
Piotroski F-Score
1/9
#7,860
Month to date
-24.0%
View ranking
YTD
-68.3%
View ranking

Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

View All

No recent news available for BDMDW.

SEC Filings

View All

[6-K] 30 business days below $1 start a compliance clock for Baird Medical (Nasdaq: BDMD).

[SCHEDULE 13G] 2.48M conversion shares are excluded from a fund's reported Baird Medical (BDMD) stake.

[6-K] An 8% discount accompanies Baird Medical (BDMD)'s new 12-month convertible note.

[6-K] An $11.4M net loss gives way to a profit at Baird Medical (BDMD).

[424B5] Baird Medical (BDMD) could issue up to 27.5 million shares if its note converts at the price floor.

[6-K] U.S. sales rise to 27% at Baird Medical (BDMD) as profit returns, with just $0.29M in cash

[3] Baird Medical Investment (BDMD) stake structure detailed by ExcelFin SPAC

[SCHEDULE 13D] Baird Medical Investment (BDMD) holders detail 19.1% ownership stake

[20-F/A] Baird Medical (Nasdaq: BDMD) swings to 2025 loss amid China slowdown

[SCHEDULE 13G] Alta Partners holds 1.995M shares in Baird Medical (BDMD) via warrants

Baird Medical Investment Holdings Warrant has filed 10 recent SEC filings, including 4 Form 6-K, 2 Form SCHEDULE 13G, 1 Form 3, 1 Form 424B5. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BDMDW SEC filings →

Financial Highlights

View Full Financials

Baird Medical Investment Holdings Warrant generated $22.5M in revenue in FY2025, retaining a 83.8% gross margin, operating income reached -$25.6M, and net income was -$27.3M. Diluted earnings per share stood at -$0.98. The company generated -$1.3M in operating cash flow. The current ratio was 1.70, measuring current assets divided by current liabilities.

$22.5M
Revenue (FY2025)
-$27.3M
Net Income (FY2025)
-$0.98
Diluted EPS (FY2025)
-$1.3M
Operating Cash Flow
83.8%
Gross Profit Margin
1.70
Current Ratio

Upcoming Events

No upcoming events scheduled for BDMDW.

Short Interest History

Last 12 Months

Short interest in Baird Medical Investment Holdings Warrant (BDMDW) currently stands at 12.9 thousand shares. Since November 2025, short interest has decreased by 32.5%.

Days to Cover History

Last 12 Months

Days to cover for Baird Medical Investment Holdings Warrant (BDMDW) currently stands at 25.7 days, up 217.7% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 31.7%. Across the settlements charted above, it has ranged from 1.0 to 722.7 days.

Frequently Asked Questions

The current quoted price of Baird Medical Investment Holdings Warrant (BDMDW) is $0.0189 as of November 6, 2026.

The FY2025 revenue of Baird Medical Investment Holdings Warrant (BDMDW) is $22.5M, from its most recent completed fiscal year.

The FY2025 net income of Baird Medical Investment Holdings Warrant (BDMDW) is -$27.3M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Baird Medical Investment Holdings Warrant (BDMDW) is -$0.98 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Baird Medical Investment Holdings Warrant (BDMDW) is -$1.3M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The gross profit margin of Baird Medical Investment Holdings Warrant (BDMDW) is 83.8% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Baird Medical Investment Holdings Warrant (BDMDW), current assets divided by current liabilities, was 1.70 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Baird Medical Investment Holdings Warrant (BDMDW) is $18.9M for FY2025, its most recent completed fiscal year.

The operating income of Baird Medical Investment Holdings Warrant (BDMDW) is -$25.6M for FY2025, its most recent completed fiscal year. Learn about operating income.